Medifast Inc (MED) Stock Price, Quote & News

Company Profile

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding,...

Industry: Personal Services

Sector: Consumer Cyclical

Phone: 410 581 8042

Website: medifastinc.com

Address:

100 International Drive, 18th Floor, Baltimore, United States

SuperGreenToday Nov. 11 at 1:39 PM

$MED Share Price: $11.80 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $2.03 – $2.50 Target Zone: $3.75 – $4.59 Potential Upside: 75% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

justcomments Nov. 5 at 7:08 PM

$MED I noticed a pattern in MED. They say they lost money. Then the cash in bank increases. This quarter they made 10.8M dollars. That's 98 cents per share. That's a lot of money for a small cap like this. They say they had a really bad quarter. The profit margin fell from 70% to 69.5%. Is that right? Did I hear it correctly? That's a disaster, no? What's the next quarter profit margin? 69.3%? Keep shorting.

0 · Reply

justcomments Nov. 5 at 6:43 PM

$MED OZEMPIC awareness is slowly spreading. Very slowly. Pancreatitis cancer. Thyroid cancer. Kidney damage. Heart failure. Gastrointestinal paralysis. Eye problems. This is serious. When these people decide to go back to food - it will be interesting for MED.

0 · Reply

_StockFox_ Nov. 5 at 12:48 AM

$MED added a few shares today $SPY $QQQ

0 · Reply

ZacksResearch Nov. 4 at 5:09 PM

$MED feels the pinch from fewer OPTAVIA Coaches, but shifting focus could spark a new phase 🔄💪 Q3 results showed coach declines weighing on performance, yet the company’s pivot toward metabolic health signals a strategic growth move. Full story on the transition here 👉 https://www.zacks.com/stock/news/2784765/medifasts-q3-loss-wider-than-expected-sales-decline-36-yy?cid=sm-stocktwits-2-2784765-teaser-19330&ADID=SYND_STOCKTWITS_TWEET_2_2784765_TEASER_19330

0 · Reply

ZacksResearch Nov. 4 at 4:09 PM

$MED misses on EPS — is the shift to metabolic health the right move? 🤔 📉 EPS loss of 21 cents vs. expected 1 cent loss 📊 Revenue of $89.4M beats estimate but drops 36.2% YoY 🚪 Active earning OPTAVIA coaches down 35% amid GLP-1 adoption Full breakdown here 👉 https://www.zacks.com/stock/news/2784765/medifasts-q3-loss-wider-than-expected-sales-decline-36-yy?cid=sm-stocktwits-2-2784765-body-19331&ADID=SYND_STOCKTWITS_TWEET_2_2784765_BODY_19331

0 · Reply

DataJim Nov. 4 at 3:48 PM

$MED Have they given any insight into when they will return to profitability? the Q4 projected loss is the biggest one yet.

1 · Reply

justcomments Nov. 4 at 3:31 AM

$MED one number really stands out: 173.5M dollars. They say they lose money all the time, but the cash in the bank keeps going up. It makes me wonder how they are pulling it off. I got to admit is it a little bit unclear.

0 · Reply

lecorb Nov. 3 at 11:48 PM

$MED Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health. https://seekingalpha.com/news/4513798-medifast-outlines-q4-2025-revenue-guidance-of-65m-80m-amid-strategic-shift-to-metabolic?mailingid=42316712&messageid=2900&position=rta_news_adlength_shortad_main_0_title&serial=42316712.295&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha&utm_term=42316712.295

0 · Reply

onlythebestcompanies Nov. 3 at 1:03 AM

$MED $20 soon.

1 · Reply

Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

Nov 3, 2025, 6:36 PM EST - 10 days ago

Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 4:05 PM EST - 10 days ago

Medifast Announces Third Quarter 2025 Financial Results

Oct 27, 2025, 8:30 AM EDT - 18 days ago

Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

Oct 21, 2025, 10:00 AM EDT - 24 days ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

Sep 15, 2025, 8:30 AM EDT - 2 months ago

Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes

Aug 4, 2025, 11:56 PM EDT - 3 months ago

Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 4:05 PM EDT - 3 months ago

Medifast Announces Second Quarter 2025 Financial Results

LFMD

Jul 21, 2025, 4:05 PM EDT - 4 months ago

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025

Jul 3, 2025, 2:48 AM EDT - 4 months ago

Medifast: Coach Surge Fuels Growth

Apr 28, 2025, 6:03 PM EDT - 7 months ago

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 4:05 PM EDT - 7 months ago

Medifast Announces First Quarter 2025 Financial Results

LFMD

Mar 28, 2025, 9:21 AM EDT - 8 months ago

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect

Feb 18, 2025, 7:06 PM EST - 9 months ago

Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 4:05 PM EST - 9 months ago

Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 4, 2025, 4:05 PM EST - 10 months ago

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

Jan 7, 2025, 8:30 AM EST - 11 months ago

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

Dec 5, 2024, 8:30 AM EST - 1 year ago

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

Nov 6, 2024, 8:02 AM EST - 1 year ago

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued

Nov 4, 2024, 5:56 PM EST - 1 year ago

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

Medifast Announces Third Quarter 2024 Financial Results

Oct 21, 2024, 4:05 PM EDT - 1 year ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Oct 3, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Oct 1, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholders To Join An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Sep 27, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Sep 26, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Contact The Schall Law Firm

Sep 25, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Sep 21, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Medifast, Inc. For Securities Fraud

Sep 20, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc May Have Violated Securities Laws And Investors Are Urged To Help The Schall Law Firm Investigate

Sep 19, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 17, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Contributions To A Securities Fraud Inquiry Into Medifast, Inc.

Sep 15, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Defrauded The Public And The Schall Law Firm Invites Stockholders To Join A Securities Fraud Inquiry

$The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake$

Sep 14, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake

Sep 13, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Committed Securities Fraud And Shareholders With Losses Are Urged To Contribute To The Schall Law Firm's Inquiry

$The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out$

Sep 12, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out

Sep 11, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Committed Securities Fraud And Shareholders Can Join The Schall Law Firm's Inquiry

Sep 9, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. Might Have Committed Securities Fraud And Impacted Shareholders Can Join The Schall Law Firm's Inquiry

Sep 7, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation

Sep 5, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation

Sep 4, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out

Sep 3, 2024, 11:00 AM EDT - 1 year ago

Investors With Losses In Medifast Inc Are Encouraged To Help The Schall Law Firm In A Securities Fraud Investigation

Sep 3, 2024, 6:22 AM EDT - 1 year ago

Medifast: Reorganization, GLP-1 Medication, And FCF Imply Undervaluation

SuperGreenToday Nov. 11 at 1:39 PM

0 · Reply

justcomments Nov. 5 at 7:08 PM

0 · Reply

justcomments Nov. 5 at 6:43 PM

0 · Reply

_StockFox_ Nov. 5 at 12:48 AM

$MED added a few shares today $SPY $QQQ

0 · Reply

ZacksResearch Nov. 4 at 5:09 PM

0 · Reply

ZacksResearch Nov. 4 at 4:09 PM

0 · Reply

DataJim Nov. 4 at 3:48 PM

$MED Have they given any insight into when they will return to profitability? the Q4 projected loss is the biggest one yet.

1 · Reply

justcomments Nov. 4 at 3:31 AM

0 · Reply

lecorb Nov. 3 at 11:48 PM

0 · Reply

onlythebestcompanies Nov. 3 at 1:03 AM

$MED $20 soon.

1 · Reply

justcomments Oct. 31 at 10:13 PM

$MED I learned one lesson in my investing life - and the lesson is to never buy a stock with dumb management. I think I made that mistake when I bought MED.

2 · Reply

justcomments Oct. 31 at 6:18 PM

$MED oh, so it broke down bellow 12. Wow. It's becoming obvious they should all be fired. Starting with the golden mouth CEO. Talk is cheap. That's all he does very well. Talking talking talking BS. How can you run a food sales company with a margin of 70% and drop the stock price with every word? It's food. Best selling product on the planet. Food always sells. Why don't they find a nice talking point about food sales? Find a bar or something and compete with it. Food sales. That's all.

0 · Reply

justcomments Oct. 29 at 8:09 PM

$MED I am wondering what the golden mouth man comes up with this time. I hope his speech is not too long. If he talks too much - the stock will likely get beaten up on open next day.

0 · Reply

justcomments Oct. 24 at 6:19 PM

$MED what a piece of s

0 · Reply

justcomments Oct. 21 at 5:52 PM

$MED I hope the next earnings release will be concise like the AI writeup of the previous one. Quote: "Based on its latest earnings release, Medifast is transforming its business model to address declining sales and adapt to the market impact of GLP-1 weight-loss medications. The company's strategy involves revitalizing its coach network, expanding product lines like OPTAVIA ASCEND for GLP-1 users, and partnering with LifeMD to integrate GLP-1 access with its programs, emphasizing a long-term approach to metabolic health." Now let's see if Mr Chard can do it better....

0 · Reply

_StockFox_ Oct. 9 at 1:58 PM

$HLF $INMD $TZOO $MED I rather be load now rather than chase when the time comes...easy multibagger on each of these..at some point.... Buy contractions...sell expansions.... (of good companies)

0 · Reply

ObsidianTrend Oct. 5 at 11:34 AM

$MED Healthcare services growth. Testing resistance level. Volume expansion needed for continuation. Sector momentum.

0 · Reply

_StockFox_ Oct. 3 at 11:25 PM

$MED remember what I said 🦊🦊 $SPY $QQQ

0 · Reply

Winning76 Sep. 30 at 2:41 PM

$MED biggest scam they stole everyone's money 🤑

0 · Reply

justcomments Sep. 25 at 4:14 AM

$MED somebody please buy them out. Even watching this hurts. Not to mention being a long term shareholder. Ugh.

0 · Reply

_StockFox_ Sep. 22 at 4:17 AM

I believe adding to these to pay off in due time...GLTA $TZOO $MED $VST $CRCT

0 · Reply

ZacksResearch Sep. 19 at 6:35 PM

$MED is redefining health and wellness with its strategic pivot — but is it enough to restore growth? 📉 Medifast is expanding its OPTAVIA coaching network, launching new product lines like ACTIVE and ASCEND, and enhancing digital tools to boost growth. Yet, shares have fallen 17.3% YTD, trading at a low 0.36X forward P/S ratio. ⚖️ Discover more about MED's strategic focus on future success here 👉 https://www.zacks.com/stock/news/2754147/will-medifasts-strategic-endeavors-deliver-growth-in-2025?cid=sm-stocktwits-2-2754147-body-13398&ADID=SYND_STOCKTWITS_TWEET_2_2754147_BODY_13398

0 · Reply

Market Cap	127.83M
Revenue (ttm)	602.46M
Net Income (ttm)	2.09M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	582.50
Profit Margin	0.35%
Debt to Equity Ratio	0.00

Volume	48,417
Avg Vol	156,814
Day's Range	N/A - N/A
Shares Out	10.99M
Stochastic %K	18%
Beta	0.82
Analysts	Hold
Price Target	$15.00